Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Biomarkers, Tumor analysis MeSH
- Rectal Neoplasms chemistry pathology radiotherapy MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Transcription Factor RelA analysis MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Biomarkers, Tumor MeSH
- Transcription Factor RelA MeSH
Objectives Nuclear factor-kappaB (NF-kappaB), especially p65 subunit, seems to be associated with origin and progression of cancer. The aim of the study was to determine expression of NF-kappaB/p65 in rectal cancer patients before and after radiotherapy as well as to assess the relationship between NF-kappaB/p65 expression, other tumor characteristics, and disease progression. Further aim was to evaluate whether expression of NF-kappaB/p65 in tumor tissue may serve as a predictive marker of patient outcome. Patients and methods Twenty-five patients with rectal cancer undergoing pre-operative radiotherapy were included in the study. Unirradiated rectal cancer specimens were obtained from diagnostic colonoscopy. Irradiated rectal cancer specimens were obtained from surgically removed part of the rectum with the tumor. NF-kappaB/p65 expression was determined by immunohistochemistry. Results Cytoplasmic positivity in cancer cells and nuclear positivity in lymphocytes were detected. In post-radiotherapy specimens single tumor cells or small clones of them deeply infiltrating the wall of the rectum, that were characterized by high NF-kappaB/p65 expression, were found. Patients with presence of these cells in post-radiotherapy specimens have worse clinical outcome in terms of overall survival and disease-free interval. Conclusion While the NF-kappaB/p65 positive staining of the epithelial cells did not have any clinical implications in this study, it may be of clinical significance in the future. Residual invasively growing cancer cells with high NF-kappaB/p65 positivity found in specimens after radiotherapy and surgery may be used to find what patients have a worse outcome. Thus, patients being at risk of cancer progression and requiring more aggressive anti-cancer therapy may be identified.
See more in PubMed
Br J Cancer. 2005 Oct 31;93(9):1019-23 PubMed
J Surg Res. 2004 Aug;120(2):178-88 PubMed
Mol Cell Biol. 1994 May;14(5):3276-82 PubMed
Genes Dev. 1995 Nov 15;9(22):2723-35 PubMed
Neoplasma. 2006;53(6):518-23 PubMed
Int J Mol Med. 2002 Nov;10(5):547-50 PubMed
Virchows Arch. 2005 May;446(5):475-82 PubMed
Int J Colorectal Dis. 2004 Jan;19(1):18-22 PubMed
Annu Rev Immunol. 2000;18:621-63 PubMed
Oncology. 2003;65(1):37-45 PubMed
Inflamm Res. 1998 Nov;47(11):440-5 PubMed
Trends Immunol. 2004 Jun;25(6):280-8 PubMed
J Pathol. 2004 Dec;204(5):569-77 PubMed
Mol Cancer Ther. 2004 Jun;3(6):693-8 PubMed
J Clin Invest. 2001 Feb;107(3):241-6 PubMed
Nat Rev Cancer. 2002 Apr;2(4):301-10 PubMed
Carcinogenesis. 2005 Aug;26(8):1395-403 PubMed
Annu Rev Immunol. 1998;16:225-60 PubMed
J Clin Oncol. 2005 Aug 20;23(24):5644-50 PubMed
Annu Rev Immunol. 1996;14:649-83 PubMed
